Formulation Comparison in Normal Volunteers

Completed · Phase 1

Conditions studied: Normal Volunteers

In brief

This is a double-masked, single-center, crossover study in which normal volunteers will be randomized to receive one of two formulations of 0.5% AR-12286 Ophthalmic Solution for 8 days. Subjects will undergo a minimum 7-day washout, and then receive the alternate treatment for 8 days.

Key facts

Study ID

NCT01250197

Run by

Aerie Pharmaceuticals

People needed

18

Starts

2010-11-01

Expected to finish

2010-12-01

Last updated by the study team

2010-12-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Normal volunteers

You may not qualify if…

• Active ophthalmic or systemic disease

Where it is running

• Celerion — Phoenix, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.